News
There are a number of key data requirements that are necessary for an FEP project to have the best chance ...
The understanding of Alzheimer’s, Parkinson’s, dementia, amyotrophic lateral sclerosis (ALS) / motor neurone and Huntington’s disease is evolving rapidly. Research ...
While the development of novel antibiotics is undoubtably a challenge, novel computational technologies and approaches do offer complementary strategies that ...
Does technology hold the potential to solve some of the most pressing challenges in drug discovery such as changing working ...
The globalized outsourcing model of modern drug discovery is driving efficiencies across the Design-Make-Test-Analyze (DMTA) cycle. With projects typically involving ...
As PFAS substances come under the spotlight for their environmental impact, we explore approaches to redesigning fluorinated compounds within a ...
Rob Scoffin, CEO, speaks to the Life Sciences Knowledge Hub about innovation and how Cresset are navigating the unprecedented changes ...
Although the World Health Organization (WHO) has declared that Covid-19 no longer represents a global health emergency, the threat from ...
Find out what’s involved in running a Free Energy Perturbation (FEP) project and how Cresset Discovery can support or completely ...
We explore some of the challenges of fragment-based drug discovery (FBDD) and how Cresset Discovery’s expert modelers apply their deep ...
As targeted protein degradation continues to evolve as a new therapeutic modality, specialist computational approaches can provide deep insights to ...
Cambridge, UK – 17 January, 2023 – Cresset Discovery, provider of molecular modeling expertise for drug discovery, is collaborating with ...